The clinical data domain is going through major changes and is full of opportunities. This discussion delves into the industry with one of its biggest players. Sramana Mitra: Let’s introduce our audience to you as well as Medidata. Tarek Sherif: I’m Tarek Sherif. I’m a Co-Founder, the CEO, and Chairman of Medidata Solutions. We’re a
This feature from CNET follows the annual Game Developers Conference held in San Francisco last week. For this week’s posts, click on the paragraph links.
Rahul Chowdhri, Investor at Stellaris Venture Partners, shares some fascinating examples of consumer ventures catering to the next 400 million consumers in India.
Sramana Mitra: In selecting customers to go after, what is the positioning of your company? Are you going after large enterprises? Are you going after mid-market? Are you going after small businesses? Each of them has a slightly different go-to market strategy. The inside sales point that you raise is very interesting. Freshdesk, now Freshworks,
Rebecca Kaden, General Partner at Union Square Ventures, discusses her firm’s capital efficient investment thesis and debates the pros and cons of blitzscaling.
Nandini Mansinghka: I think what has happened is that even in our portfolio, once in a while we do come across a company that looks like a potential unicorn. And that’s when you finally see a lot of investors coming in. Over a period of time, we haven’t always seen that case. So the ones
I’m publishing this series on LinkedIn called Colors to explore a topic that I care deeply about: the Renaissance Mind. I am just as passionate about entrepreneurship, technology, and business, as I am about Art and Culture. In this series, I will typically publish a piece of Art – a painting, a poem, a piece
Sramana Mitra: One point I will double-click on which comes up a lot is that we have a huge overlap in the Indian market. 1Mby1M has a big presence in the Indian market and we’ve been present for a very long time. The whole Indian SaaS category was one that we played a very big